ATEX Financials

Income Statement
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026
Revenue
2.0M
+0.0%
2.0M
+24.5%
1.6M
+1.4%
1.6M
+9.4%
1.4M
Cost of Revenue
0
0
0
0
0
Gross Profit
2.0M
+0.0%
2.0M
+24.5%
1.6M
+1.4%
1.6M
+9.4%
1.4M
Operating Expenses
12.9M
-15.6%
15.2M
+29.4%
11.8M
-1.3%
11.9M
-13.6%
13.8M
R&D
1.2M
-3.7%
1.3M
+14.8%
1.1M
-8.9%
1.2M
+8.2%
1.1M
SG&A
11.5M
+4.1%
11.1M
+9.7%
10.1M
+2.5%
9.8M
-17.5%
11.9M
Operating Income
-10898000
+17.9%
-13267000
-30.1%
-10195000
+1.7%
-10375000
+16.2%
-12388000
EBITDA
-10797000
-3.9%
-10388000
-7.9%
-9626000
-1.3%
-9507000
+18.4%
-11644000
Net Income
240.0K
-98.7%
18.5M
+380.6%
-6601000
-112.3%
53.5M
+112.6%
25.2M
EPS (Basic)
$0.01
-99.0%
$0.99
+382.9%
$-0.35
-112.2%
$2.86
+111.9%
$1.35
EPS (Diluted)
$0.01
-99.0%
$0.98
+380.0%
$-0.35
-112.2%
$2.86
+111.9%
$1.35
Shares (Diluted)
19.6M
+3.7%
18.9M
+1.3%
18.7M
-0.1%
18.7M
+0.0%
18.7M
Anterix (ATEX) โ€” Financials